Literature DB >> 16804474

Breast cancer trends among young women in the United States.

Robert E Tarone1.   

Abstract

BACKGROUND: It has been suggested that exposures associated with industrialization have increased breast cancer risk among young women in recent decades in the United States despite data demonstrating declining breast cancer mortality in birth cohorts born after 1945.
METHODS: Trends for in situ and invasive breast cancer incidence rates from 1975 through 2002 among white and black U.S. women ages 20 to 49 are evaluated by decade of age using linear regression analyses.
RESULTS: Despite increasing rates of in situ breast cancer after 1980 reflecting increased use of mammography, invasive breast cancer rates declined for both white and black women under age 50. These declines are consistent with a decrease in birth cohort risk of breast cancer for women born after 1945.
CONCLUSIONS: Invasive breast cancer incidence rates are not increasing in young U.S. women despite increases in mammography and trends in known risk factors (eg, reproductive factors) that would predict increasing risk.

Entities:  

Mesh:

Year:  2006        PMID: 16804474     DOI: 10.1097/01.ede.0000229195.98786.ee

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  16 in total

1.  Renal cell carcinoma with isolated breast metastasis.

Authors:  Sarah M Dhannoon; Ali A Alsaad; Abdo R Asmar; Fuad H Shahin
Journal:  BMJ Case Rep       Date:  2017-06-15

2.  Breast Carcinoma in Young Women: No Evidence of Increasing Rates of Metastatic Breast Carcinoma in a Single Tertiary Center Review.

Authors:  Niamh Conlon; Jane Howard; Jeffrey Catalano; Meighan Gallagher; Lee K Tan; Adriana D Corben
Journal:  Breast J       Date:  2016-02-29       Impact factor: 2.431

Review 3.  How many etiological subtypes of breast cancer: two, three, four, or more?

Authors:  William F Anderson; Philip S Rosenberg; Aleix Prat; Charles M Perou; Mark E Sherman
Journal:  J Natl Cancer Inst       Date:  2014-08-12       Impact factor: 13.506

4.  Divergent estrogen receptor-positive and -negative breast cancer trends and etiologic heterogeneity in Denmark.

Authors:  William F Anderson; Philip S Rosenberg; Lucia Petito; Hormuzd A Katki; Bent Ejlertsen; Marianne Ewertz; Birgitte B Rasmussen; Maj-Britt Jensen; Niels Kroman
Journal:  Int J Cancer       Date:  2013-06-13       Impact factor: 7.396

5.  Protein expression profile and prevalence pattern of the molecular classes of breast cancer--a Saudi population based study.

Authors:  Dalal M Al Tamimi; Mohamed A Shawarby; Ayesha Ahmed; Ammar K Hassan; Amal A AlOdaini
Journal:  BMC Cancer       Date:  2010-05-21       Impact factor: 4.430

6.  Age-related crossover in breast cancer incidence rates between black and white ethnic groups.

Authors:  William F Anderson; Philip S Rosenberg; Idan Menashe; Aya Mitani; Ruth M Pfeiffer
Journal:  J Natl Cancer Inst       Date:  2008-12-09       Impact factor: 13.506

7.  Reproductive factors and risk of premenopausal breast cancer by age at diagnosis: are there differences before and after age 40?

Authors:  Erica T Warner; Graham A Colditz; Julie R Palmer; Ann H Partridge; Bernard A Rosner; Rulla M Tamimi
Journal:  Breast Cancer Res Treat       Date:  2013-10-18       Impact factor: 4.872

8.  Recent trends in breast cancer among younger women in the United States.

Authors:  Louise A Brinton; Mark E Sherman; J Daniel Carreon; William F Anderson
Journal:  J Natl Cancer Inst       Date:  2008-11-11       Impact factor: 13.506

9.  Clinical Significance of Age at the Time of Diagnosis among Young Breast Cancer Patients.

Authors:  Im-Kyung Kim; Seho Park; Hyewon Hwang; Jun Sang Lee; Si Mon Ko; Seung Il Kim; Byeong-Woo Park
Journal:  J Breast Cancer       Date:  2011-12-27       Impact factor: 3.588

Review 10.  Pregnancy and breast cancer: when they collide.

Authors:  Traci R Lyons; Pepper J Schedin; Virginia F Borges
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-04-21       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.